CJC + IPA

CJC + IPA is a two-component research blend with a listed total quantity of 10mg. The selected variation specifies 5mg CJC-1295 (no DAC) and 5mg ipamorelin, giving the formulation an equal-mass composition.

The no-DAC designation is an important part of the CJC component’s identity. It distinguishes the listed material from CJC-1295 products described with DAC, rather than serving as an optional abbreviation. When comparing catalog entries or chemical references, retain that qualifier alongside the CJC name.

Ipamorelin is a synthetic pentapeptide, meaning its structure contains five amino acid residues. It is a distinct component of this formulation, not another name for CJC. The blend’s 10mg total combines the two listed amounts and should not be read as 10mg of each ingredient.

For researchers comparing product formats, QURE also lists ipamorelin separately. That individual product and this blend have different stated compositions, even though they share one named ingredient.

An equal-mass blend does not establish an equal molar ratio or demonstrate an interaction between its components. This listing describes material identity and quantity without predicting experimental outcomes. Consult the selected product information and any relevant document in the COA library before treating a general chemical reference as a specification for the supplied material.

For research use only. Not for human or veterinary use, consumption, or administration.